Skip to main content
logo
Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
11.56
+0.01 (0.09%)
Apr 30, 2026, 3:04 PM CST

SHE:002900 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
3,5753,8573,0494,2284,2296,453
Market Cap Growth
4.43%26.48%-27.88%-0.01%-34.47%125.19%
Enterprise Value
4,1184,1643,1263,8153,6756,009
Last Close Price
11.5512.469.7113.1913.0919.47
PE Ratio
--51.9757.40139.9918.39
Forward PE
-40.2640.2640.2640.2640.26
PS Ratio
4.404.892.693.564.116.82
PB Ratio
2.022.171.411.972.063.05
P/TBV Ratio
2.192.351.492.092.143.18
P/FCF Ratio
----76.30-
P/OCF Ratio
--99.37118.4529.24-
EV/Sales Ratio
5.065.282.763.223.576.35
EV/EBITDA Ratio
--23.4742.1956.52-
EV/EBIT Ratio
--95.56---
EV/FCF Ratio
-13.33---66.31-
Debt / Equity Ratio
0.580.630.430.330.320.23
Debt / EBITDA Ratio
--6.517.138.80-
Debt / FCF Ratio
----11.85-
Net Debt / Equity Ratio
0.310.290.04-0.15-0.31-0.29
Net Debt / EBITDA Ratio
-4.68-3.570.70-3.65-9.8010.36
Net Debt / FCF Ratio
-1.75-1.79-0.301.25-11.507.21
Asset Turnover
0.230.220.310.350.320.34
Inventory Turnover
1.831.812.152.572.271.82
Quick Ratio
0.580.610.861.362.382.32
Current Ratio
0.880.871.171.702.722.66
Return on Equity (ROE)
-16.38%-17.34%2.55%3.34%1.27%17.89%
Return on Assets (ROA)
-4.55%-4.74%0.56%-0.15%-0.63%-3.38%
Return on Invested Capital (ROIC)
-11.20%-12.13%1.47%-0.43%-1.45%-9.15%
Return on Capital Employed (ROCE)
-11.10%-11.90%1.30%-0.30%-1.20%-5.90%
Earnings Yield
-8.89%-8.81%1.92%1.74%0.71%5.44%
FCF Yield
-8.64%-7.36%-10.35%-6.24%1.31%-1.34%
Dividend Yield
1.73%-2.06%1.52%0.76%1.64%
Payout Ratio
--178.20%55.71%361.96%9.78%
Buyback Yield / Dilution
-4.78%-2.78%-0.61%-1.61%2.74%4.68%
Total Shareholder Return
-3.04%-2.78%1.44%-0.09%3.50%6.33%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.